Winner 2009: Jürg Zimmermann

Jürg Zimmermann and his team won the European Inventor of the Year Award 2009 in the "Industry"-category for a new treatment for Chronic Myelogenous Leukaemia (CML).
Chronic myelogenous leukaemia (CML) was long-considered one of the deadliest forms of cancer, capable of striking at any time, causing extreme pain and worse still, affecting both adults and young children. Before the work of two pioneering medical researchers, a diagnosis of CML and subsequent attempts at treatment guaranteed prolonged pain and no certainty of remission. But now with Glivec, a cancer fighting drug with a 98 percent remission rate, CML has lost much of its former bite thanks to American oncologist Brian Druker and Swiss medicinal chemist Jürg Zimmermann.

Follow the EPO on Twitter: http://www.twitter.com/EPOorg Read more on http://www.epo.org/european-inventor

Category:

Science & Technology

Tags:

• Zimmermann H264
• EPO
• EPA
• CML
• Zimmermamm